The Role of β2-Antiplasmin in the Inhibition of Clot Lysis in Newborns and Adults

Neonatology

Volumn 69, Issue 5, 1996, Pages 298-306

  Ries, M ^a   Klinge, J ^a   Rauch, R ^a   Keuper, H ^b   Harms, D ^a  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b Behringwerke AG   (Germany)

Author keywords

Fibrinolysis; Newborns; Plasminogen; 2 Antiplasmin

Indexed keywords

ALPHA 2 ANTIPLASMIN; PLASMINOGEN; SIALIC ACID;

ADULT; ARTICLE; BINDING AFFINITY; BLOOD CLOT LYSIS; CARBOHYDRATE ANALYSIS; CHEMICAL REACTION KINETICS; CONCENTRATION RESPONSE; CONTROLLED STUDY; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; NEWBORN; NORMAL HUMAN; PRIORITY JOURNAL;

ADULT; ANTIPLASMIN; FIBRIN; FIBRINOLYSIS; HUMANS; INFANT, NEWBORN; KINETICS; PLASMIN; PLASMINOGEN;

EID: 0029982171     PISSN: 16617800     EISSN: 16617819     Source Type: Journal    
DOI: 10.1159/000244324     Document Type: Article

References (37)

1. Ambrus CM, Ambrus JL, Choi TS, Jung O, Mirand EA, Bartfay-Szabo A: The fibrinolysin system and its relationship to disease in the newborn, Am J Pediatr Hematol Oncol 1979;1:251-260.
2. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefscn DM, Powers P: Development of the human coagulation system in the full-term infant, Blood 1987:70:165-172.
3. Corrigan JJ: Neonatal thrombosis and the thrombolytic system: Pathophysiology and therapy, Am J Pediatr Hematol Oncol 1988; 10:83-91.
4. Corrigan JJ, Sleeth JJ, Jeter MA, Lox CD: Newborn's fibrinolytic mechanism: Components and plasmili generation, Am J Hematol 1989:32:273-278.
5. Ekclund H, Hedner U, Nilsson IM: Fibrinolysis in newborns, Acta Paediatr Scand 1970;59:33-43.
6. Andrew M, Paes B, Johnston M: Development of the hemostatic system in the neonate and young infant, Am J Pediatr Hematol Oncol 1990:12: 95-104.
7. Saleh AA, Hirokawa S, Stowers MA, Hldridge DM, Dorey LG, Dotnbrowski MP, Bottoms SF, Kazzi GM, Mammen EF: Effect of mode of delivery on certain parameters of neonatal hemostasis, Thromb Hac-most 1993:69:1020.
8. Suarez CR, Walenga J, Mangogna LC, Farced J: Neonatal and maternal fibrinolysis: Activation at time of birth, Am J Hematol 1985:19: 365-372.
9. Estelles A, Aznar J, Gilabert J, Parrilla JJ: Dysfunctional plasminogen in full-term newborn, Pediatr Res 1980:14:1180-1185.
10. Benavent A, Estelles A, Aznar J, Martincz-Sales V, Gilabcrt J, Fornas E: Dysfunctional plasminogen in full-term newborn - Study of active site of plasmin, Tliromb Hac-most 1984:51:67-70.
11. Edelberg JM, Enghild JJ, Pizzo SV, Gonzales-Gronow M: Neonatal plasminogen displays altered cell surface binding and activation kinetics, Correlation with increased glycosylation of the protein, J Clin Invest 1990:86:106-112.
12. Ries M, Klinge J, Rauch R, Zenker M, Keuper H, Harms D: Plasmin generation under physiological conditions and after oxidative inactivation of inhibitors, Evidence for a variation in kinetic behaviour between plasmin and alpha-2-antiplas-min in newborn infants, Thromb Haemost 1995:73:1296.
13. Idell S, James KK, Levin EG: Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar fibrin deposition in the adult respiratory distress syndrome, J Clin Invest 1989:84:695-705.
14. Bcrtozzi P, Astedt B, Zenzius L, Lynch K, LcMairc F, Zapol W, Chapman HA: Depressed bron-choalveolar urokinase activity in patients with adult respiratory' distress syndrome, N Engl J Med 1990:322: 890-897.
15. ldell S, Peters J, James KK, Fair DS, Coalson JJ: Local abnormalities of coagulation and fibrinolytic pathways that promote alveolar fibrin deposition in the lungs of baboons with dilTusc alveolar damage, J Clin Invest 1989:84:181-193.
16. Stark CR, Abramson D, Erkan V: Intravascular coagulation and hyaline membrane disease of the newborn, Lancet 1984:ii: 1180-1181.
17. Wiman B: Human oo-antiplasmin, Methods Enzymol 1981:80:395-414.
18. Ries M, Zenker M, Klinge J, Keuper H, Harms D: Age-related differences in a clot lysis assay after adding different plasminogen activators in a plasma milieu in vitro, Am J Pediatr Ilcmatol Oncol 1995:17:260-264.
19. Andrew M, Paes B, Milner R, Johnston M, Mitchell L, Tollefscn DM, Castle V, Powers P: Development of the human coagulation system in the healthy premature infant, Blood 1988:72:1651-1657.
20. Barnard DR, Simmons MA, Hathaway WE: Coagulation studies in extremely premature infants, Pediatr Res 1979; 13:1330-1335.
21. Forestier F, Daffos F, Galactéros F, Bardakijan J, Rainaut M, Benzard Y: Hematological values of 163 normal fetuses between 18 and 30 weeks of gestation, Pediatr Res 1986:20:342-346.
22. Holmberg L, Henriksson P, Ekclund H, Astedt B: Coagulation in the human fetus, comparison with term newborn infants, J Pediatr 1974:85: 860-864.
23. Jensen AH, Josso F, Zamct P, Mon-set-Couchard M, Minkowski A: Evolution of blood clotting factor levels in premature infants during the first 10 days of life: A study of 96 cases with comparison between clinical status and blood clotting factor levels, Pediatr Res 1973:7:638-644.
24. Künzer W: Fetales Fibrinogen, Klin Wochenschr 1961:39:536-542.
25. Witt I, Müller H, KQnzcr W: Evidence for the existence of foetal fibrinogen, Thromb Diath Hcmorrh 1969:22:101-109.
26. Galanakis DK, Mossesson MW: Evaluation of the role of in vivo proteolysis (fibrinogenolysis) in prolonging the thrombin time of human umbilical cord fibrinogen, Blood 1976:48:109-118.
27. Rcganon E, Vila V, Laiz B, Gilabert J, Aznar J: Comparison of normal full-term fetal and adult fibrinogen in humans by physical and chemical analyses, Thromb Haemost 1991; 65:1235.
28. Schettini F, de Mattia D, Mautone A: Preprothrombin and prothrombin in full-term newborns, Haemostasis 1972:1:271-278.
29. Wiman B, Collen D: On the kinetics of the reaction between human anti-plasmin and plasmin, Eur J Bio-chcm 1978:84:573-578.
30. Zamarron C, Lijnen HR, Collen D: Influence of exogenous and endogenous tissue-type plasminogen activator on the lysabilitv of clots in a plasma milieu in vitro, Thromb Res 1984:35:335-345.
31. Robbie LA, Booth NA, Croll AM, Bennett B: The role of alpha-2-anti-plasmin and plasminogen activator inhibitor I in the inhibition of clot lysis, Thromb Haemost 1993:70: 301-306.
32. Sakata Y, Aoki N: Significance of cross-linking of alpha-2-plasmin inhibitor to fibrin in inhibition of fibrinolysis and in hemostasis, J Clin Invest 1982:69:536-542.
33. Jobe A, Ikegami M: Surfactant for the treatment of respiratory distress syndrome, Am Rev Rcspir Dis 1987:136:1256-1275.
34. ldell S, James KK, Coalson JJ: Fibrinolytic activity in bronchoalveo-lar lavage of baboons with diffuse alveolar damage: Trends in two forms of lung injury, Crit Care Med 1992;20:1431-1440.
35. Idell S, Kumar A, Koenig KB, Coalson JJ: Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury, Am J Respir Crit Care Med 1994:149:767-775.
36. Ambrus JL, Ambrus CM: Changes in the fibrinolysin system in infantile and adult respiratory distress syndrome, caused by trauma and/or septic shock in patients and in experimental animals, J Med 1990:21: 67-84.
37. Andrew M, Berry L: Influence of lung maturity on bronchoalvcolar fibrin deposition and clearance in lung injury syndromes, Am J Respir Crit Care Med 1994:149:572-574.